167 related articles for article (PubMed ID: 30323630)
61. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
[TBL] [Abstract][Full Text] [Related]
62. Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1-mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma.
Saraswati S; Alhaider A; Abdelgadir AM; Tanwer P; Korashy HM
Cell Commun Signal; 2019 Oct; 17(1):127. PubMed ID: 31619257
[TBL] [Abstract][Full Text] [Related]
63. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
[TBL] [Abstract][Full Text] [Related]
64. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
65. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
[TBL] [Abstract][Full Text] [Related]
66. Long non-coding RNA LINC00511 regulates the expression of microRNA-625-5p and activates signal transducers and activators of transcription 3 (STAT3) to accelerate the progression of gastric cancer.
Cui N; Sun Q; Liu H; Li L; Guo X; Shi Y; Jing C; Qin C; Zhao Y
Bioengineered; 2021 Dec; 12(1):2915-2927. PubMed ID: 34224294
[TBL] [Abstract][Full Text] [Related]
67. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
Zheng L; Chen J; Zhou Z; He Z
Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
[TBL] [Abstract][Full Text] [Related]
68. Knockdown of RAI14 suppresses the progression of gastric cancer.
Chen C; Maimaiti A; Zhang X; Qu H; Sun Q; He Q; Yu W
Onco Targets Ther; 2018; 11():6693-6703. PubMed ID: 30349303
[TBL] [Abstract][Full Text] [Related]
69. LncRNA SNHG1 regulates immune escape of renal cell carcinoma by targeting miR-129-3p to activate STAT3 and PD-L1.
Tian P; Wei JX; Li J; Ren JK; Yang JJ
Cell Biol Int; 2021 Jul; 45(7):1546-1560. PubMed ID: 33739543
[TBL] [Abstract][Full Text] [Related]
70. Activation of ERK and Mutual Regulation of Stat3 and SP1 Contribute to Inhibition of PDK1 Expression by Atractylenolide-1 in Human Lung Cancer Cells.
Xiao Q; Zheng F; Wu J; Tang Q; Wang W; Hann SS
Cell Physiol Biochem; 2017; 43(6):2353-2366. PubMed ID: 29073620
[TBL] [Abstract][Full Text] [Related]
71. Gambogic acid inhibits STAT3 phosphorylation through activation of protein tyrosine phosphatase SHP-1: potential role in proliferation and apoptosis.
Prasad S; Pandey MK; Yadav VR; Aggarwal BB
Cancer Prev Res (Phila); 2011 Jul; 4(7):1084-94. PubMed ID: 21490133
[TBL] [Abstract][Full Text] [Related]
72. Glutathione S‑transferase ω 1 promotes the proliferation, migration and invasion, and inhibits the apoptosis of non‑small cell lung cancer cells, via the JAK/STAT3 signaling pathway.
Wang K; Zhang FL; Jia W
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236161
[TBL] [Abstract][Full Text] [Related]
73. The G-protein-coupled bile acid receptor Gpbar1 (TGR5) suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway.
Guo C; Su J; Li Z; Xiao R; Wen J; Li Y; Zhang M; Zhang X; Yu D; Huang W; Chen WD; Wang YD
Oncotarget; 2015 Oct; 6(33):34402-13. PubMed ID: 26417930
[TBL] [Abstract][Full Text] [Related]
74. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression.
Xie J; Chen M; Zhou J; Mo MS; Zhu LH; Liu YP; Gui QJ; Zhang L; Li GQ
Oncol Rep; 2014 Apr; 31(4):1715-22. PubMed ID: 24573489
[TBL] [Abstract][Full Text] [Related]
75. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
Zhu BH; Chen HY; Zhan WH; Wang CY; Cai SR; Wang Z; Zhang CH; He YL
World J Gastroenterol; 2011 May; 17(18):2315-25. PubMed ID: 21633597
[TBL] [Abstract][Full Text] [Related]
76. Suppression of FAK by nexrutine inhibits gastric cancer progression.
Zhuang K; Guo H; Tang H; Yan Y; Yang Z; Wang Y
Life Sci; 2020 Sep; 257():118100. PubMed ID: 32679149
[TBL] [Abstract][Full Text] [Related]
77.
Yu J; Zhang X; Ma Y; Li Z; Tao R; Chen W; Xiong S; Han X
Cancer Biother Radiopharm; 2021 Feb; 36(1):95-105. PubMed ID: 32552008
[No Abstract] [Full Text] [Related]
78. SHP-2 Interacts with CD81 and Regulates the Malignant Evolution of Colorectal Cancer by Inhibiting Epithelial-Mesenchymal Transition.
Yuan H; Zhao J; Yang Y; Wei R; Zhu L; Wang J; Ding M; Wang M; Gu Y
Cancer Manag Res; 2020; 12():13273-13284. PubMed ID: 33380834
[TBL] [Abstract][Full Text] [Related]
79. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
[TBL] [Abstract][Full Text] [Related]
80. USP29 activation mediated by FUBP1 promotes AURKB stability and oncogenic functions in gastric cancer.
Tu R; Kang Y; Pan Y; Da Y; Ren D; Zhang R; Cai Z; Liu Y; Xu J; Ma J; Zhou Z; Yin S; Li X; Zhang P; Zhang Q; Wang J; Lu X; Zhang C
Cancer Cell Int; 2024 Jan; 24(1):33. PubMed ID: 38233848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]